Testing a hamster model for COVID-19 vaccine development
Task V20: Hamster Sarbecovirus Challenge Model for SARS-CoV-2 Vaccine Testing
This study is looking at new COVID-19 vaccines using hamsters to see how well they work and if they're safe, with the hope that what we learn will help improve vaccines for everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Battelle Centers/pub Hlth Res & Evaluatn NIH-funded |
| Lab location | 1 site (Columbus, United States) |
| Project ID | NIH-11202805 on NIH RePORTER |
What this research studies
This research focuses on developing and testing vaccines for COVID-19 using a hamster model to evaluate their effectiveness and safety. The approach includes various stages of product development, from early feasibility studies to the necessary testing for regulatory approval. Patients may benefit from the insights gained through this research, as it aims to enhance the development of vaccines against COVID-19 and other infectious diseases. The study involves rigorous testing of immune responses and safety assessments.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals at risk for COVID-19 or those interested in vaccine development.
Not a fit: Patients who are not at risk for COVID-19 or those who are not interested in vaccine-related research may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective vaccines against COVID-19 and similar infectious diseases.
How similar studies have performed: Other research has shown success in using animal models for vaccine testing, indicating that this approach is well-established.
Where this research is happening
Columbus, United States
- Battelle Centers/pub Hlth Res & Evaluatn — Columbus, United States (Active)
Researchers
- Principal investigator: Rudge, Thomas — Battelle Centers/pub Hlth Res & Evaluatn
- Study coordinator: Rudge, Thomas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.